As prior noted, in vivo preclinical studies have demonstrated that PI3K-δ inhibition and knockout favorably increase the CD8+ TIL/Treg ratios in mouse models of lung, breast, and colon cancer (36). The gene discussed is CD8A; the disease is malignant colon neoplasm.